Paper3262014
In vitro generation of effector cells cytotoxic to autologous targets from chronic myeloid leukemia patients in remission.
Somasundaram R and 3 others. Cancer Immunol Immunother, 1988. Cited by 8 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. In vitro generation of effector cells cytotoxic to autologous targets from chronic myeloid leukemia patients in remission. Papers, record 3262014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3262014
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In vitro generation of effector cells cytotoxic to autologous targets from chronic myeloid leukemia patients in remission.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leukemia, Myeloid | Major topic |
| T-Lymphocytes, Cytotoxic | Major topic |
| Bone Marrow | |
| Hematopoietic Stem Cells | |
| Humans | |
| In Vitro Techniques |
Source PubMed
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6,595,217 | Normal responsiveness of granulocyte macrophage committed stem cells from patients with chronic myeloid leukemia to proliferation inhibition by prostaglandin E 1. | Indian J Exp Biol | 1984 | https://conductscience.org/library/papers/6595217 | PubMed |
| 2 | 6,604,875 | T-lymphocyte--mediated granulopoietic failure. In vitro identification of prednisone-responsive patients. | N Engl J Med | 1983 | https://conductscience.org/library/papers/6604875 | PubMed |
| 3 | 3,493,226 | Production of stable cytolytic T-cell clones directed against autologous human melanoma. | Int J Cancer | 1987 | https://conductscience.org/library/papers/3493226 | PubMed |
| 4 | 300,256 | Stimulation by human placental conditioned medium of hemopoietic colony formation by human marrow cells. | Blood | 1977 | https://conductscience.org/library/papers/300256 | PubMed |
| 5 | 305,461 | Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia. | J Exp Med | 1978 | https://conductscience.org/library/papers/305461 | PubMed |
| 6 | 224,318 | Continuous culture of T cells cytotoxic for autologous human leukaemia cells. | Nature | 1979 | https://conductscience.org/library/papers/224318 | PubMed |
| 7 | 1,066,526 | Generation of cytotoxic lymphocytes in vitro against autologous human leukaemia cells. | Nature | 1976 | https://conductscience.org/library/papers/1066526 | PubMed |
| 8 | 6,176,669 | Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. | J Exp Med | 1982 | https://conductscience.org/library/papers/6176669 | PubMed |
| 9 | 6,460,704 | Specific cytotoxicity against autologous tumour and proliferative responses of human lymphocytes grown in interleukin 2. | Int J Cancer | 1982 | https://conductscience.org/library/papers/6460704 | PubMed |
| 10 | 6,235,143 | Generation of human cytotoxic T lymphocytes against fresh autologous and allogeneic solid tumors by mixed lymphocyte tumor cell culture with T cell growth factor. | Gan | 1984 | https://conductscience.org/library/papers/6235143 | PubMed |
| 11 | 914,394 | Lymphocyte cytotoxicity against autologous tumour biopsy cells in humans. | Int J Cancer | 1977 | https://conductscience.org/library/papers/914394 | PubMed |
| 12 | 86,634 | Human tumor-lymphocyte interaction in vitro. VI. Specificity of primary and secondary autologous lymphocyte-mediated cytotoxicity. | J Natl Cancer Inst | 1979 | https://conductscience.org/library/papers/86634 | PubMed |
| 13 | 6,457,001 | Tumor biopsy cells participating in systems in which cytotoxicity of lymphocytes is generated. Autologous and allogeneic studies. | Int J Cancer | 1981 | https://conductscience.org/library/papers/6457001 | PubMed |
| 14 | 3,098,321 | In vitro regulation of human hematopoiesis by natural killer cells: analysis at a clonal level. | Blood | 1987 | https://conductscience.org/library/papers/3098321 | PubMed |
| 15 | 206,649 | Sensitization of lymphocytes against pooled allogeneic cells. I. Generation of cytotoxicity against autologous human lymphoblastoid cell lines. | J Exp Med | 1978 | https://conductscience.org/library/papers/206649 | PubMed |
| 16 | 1,069,027 | Cell-mediated destruction of human leukemic cells by MHC identical lymphocytes: requirement for a proliferative trigger in vitro. | J Immunol | 1976 | https://conductscience.org/library/papers/1069027 | PubMed |
| 17 | 6,968,625 | Specific T-cell-mediated killing of autologous lung tumour cells. | Cell Immunol | 1980 | https://conductscience.org/library/papers/6968625 | PubMed |
| 18 | 3,160,380 | Allostimulation of patients' lymphocytes generates both T and NK-like cells cytotoxic for autologous melanoma. | Br J Cancer | 1985 | https://conductscience.org/library/papers/3160380 | PubMed |
| 19 | 6,977,725 | Human tumour antigens defined by cytotoxicity and proliferative responses of cultured lymphoid cells. | Nature | 1982 | https://conductscience.org/library/papers/6977725 | PubMed |
| 20 | 6,450,603 | In vitro generation of lymphocytotoxicity to autochthonous leukaemic cells in chronic myeloid leukaemia. | Br J Cancer | 1981 | https://conductscience.org/library/papers/6450603 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7,621,599 | Tetanus toxoid-specific T cell responses in severe combined immunodeficiency (SCID) mice reconstituted with human peripheral blood lymphocytes. | Clin Exp Immunol | 1995 | https://conductscience.org/library/papers/7621599 | PubMed |
| 3,262,015 | Propagation of cytotoxic effectors from chronic myeloid leukemia patients and cloning of cytotoxic T cells. | Cancer Immunol Immunother | 1988 | https://conductscience.org/library/papers/3262015 | PubMed |
| 2,526,681 | Antitumor activity in vitro in chronic myelogenous leukaemia revealed after treating peripheral cells with cytosine arabinoside. | Cancer Immunol Immunother | 1989 | https://conductscience.org/library/papers/2526681 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3262014
GET https://conductscience.org/api/papers/v1/3262014/references?page=2